NEW YORK (GenomeWeb) – Noninvasive prenatal screening from cell-free DNA is ready to replace conventional screening for trisomies 21, 18, and 13 in most women, and may have a role in screening for sex chromosome aneuploidy and selected copy number variants, according to a new position statement published today by the American College of Medical Genetics and Genomics.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.